These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

988 related items for PubMed ID: 15499605

  • 1. Selective alterations of gene expression in mice induced by MPTP.
    Xu Z, Cawthon D, McCastlain KA, Slikker W, Ali SF.
    Synapse; 2005 Jan; 55(1):45-51. PubMed ID: 15499605
    [Abstract] [Full Text] [Related]

  • 2. Mice lacking alpha-synuclein have an attenuated loss of striatal dopamine following prolonged chronic MPTP administration.
    Drolet RE, Behrouz B, Lookingland KJ, Goudreau JL.
    Neurotoxicology; 2004 Sep; 25(5):761-9. PubMed ID: 15288507
    [Abstract] [Full Text] [Related]

  • 3. Environmental enrichment in adulthood eliminates neuronal death in experimental Parkinsonism.
    Faherty CJ, Raviie Shepherd K, Herasimtschuk A, Smeyne RJ.
    Brain Res Mol Brain Res; 2005 Mar 24; 134(1):170-9. PubMed ID: 15790541
    [Abstract] [Full Text] [Related]

  • 4. Dehydroepiandrosterone (DHEA) such as 17beta-estradiol prevents MPTP-induced dopamine depletion in mice.
    D'Astous M, Morissette M, Tanguay B, Callier S, Di Paolo T.
    Synapse; 2003 Jan 24; 47(1):10-4. PubMed ID: 12422368
    [Abstract] [Full Text] [Related]

  • 5. Effects of blocking the dopamine biosynthesis and of neurotoxic dopamine depletion with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on voluntary wheel running in mice.
    Leng A, Mura A, Hengerer B, Feldon J, Ferger B.
    Behav Brain Res; 2004 Oct 05; 154(2):375-83. PubMed ID: 15313025
    [Abstract] [Full Text] [Related]

  • 6. Effect of angiotensin-converting enzyme inhibitor perindopril on interneurons in MPTP-treated mice.
    Kurosaki R, Muramatsu Y, Kato H, Watanabe Y, Imai Y, Itoyama Y, Araki T.
    Eur Neuropsychopharmacol; 2005 Jan 05; 15(1):57-67. PubMed ID: 15572274
    [Abstract] [Full Text] [Related]

  • 7. Differential effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the olfactory bulb and the striatum in mice.
    Mitsumoto Y, Mori A, Ohashi S, Nakai M, Moriizumi T.
    Neurosci Res; 2005 Jan 05; 51(1):111-5. PubMed ID: 15596247
    [Abstract] [Full Text] [Related]

  • 8. Neural mechanisms underlying motor dysfunction as detected by the tail suspension test in MPTP-treated C57BL/6 mice.
    Mori A, Ohashi S, Nakai M, Moriizumi T, Mitsumoto Y.
    Neurosci Res; 2005 Mar 05; 51(3):265-74. PubMed ID: 15710490
    [Abstract] [Full Text] [Related]

  • 9. Neuroprotective effects of genistein on dopaminergic neurons in the mice model of Parkinson's disease.
    Liu LX, Chen WF, Xie JX, Wong MS.
    Neurosci Res; 2008 Feb 05; 60(2):156-61. PubMed ID: 18054104
    [Abstract] [Full Text] [Related]

  • 10. Tyrosine hydroxylase and dopamine transporter expression following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration of the mouse nigrostriatal pathway.
    Jakowec MW, Nixon K, Hogg E, McNeill T, Petzinger GM.
    J Neurosci Res; 2004 May 15; 76(4):539-50. PubMed ID: 15114626
    [Abstract] [Full Text] [Related]

  • 11. Overexpression of Parkinson's disease-associated alpha-synucleinA53T by recombinant adeno-associated virus in mice does not increase the vulnerability of dopaminergic neurons to MPTP.
    Dong Z, Ferger B, Feldon J, Büeler H.
    J Neurobiol; 2002 Oct 15; 53(1):1-10. PubMed ID: 12360578
    [Abstract] [Full Text] [Related]

  • 12. Rapid and differential losses of in vivo dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) radioligand binding in MPTP-treated mice.
    Kilbourn MR, Kuszpit K, Sherman P.
    Synapse; 2000 Mar 15; 35(4):250-5. PubMed ID: 10657034
    [Abstract] [Full Text] [Related]

  • 13. Absence of inclusion body formation in the MPTP mouse model of Parkinson's disease.
    Shimoji M, Zhang L, Mandir AS, Dawson VL, Dawson TM.
    Brain Res Mol Brain Res; 2005 Mar 24; 134(1):103-8. PubMed ID: 15790534
    [Abstract] [Full Text] [Related]

  • 14. Oestrogens prevent loss of dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) in substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice.
    Jourdain S, Morissette M, Morin N, Di Paolo T.
    J Neuroendocrinol; 2005 Aug 24; 17(8):509-17. PubMed ID: 16011487
    [Abstract] [Full Text] [Related]

  • 15. Effect of MPTP-induced denervation on basal ganglia GABA(B) receptors: correlation with dopamine concentrations and dopamine transporter.
    Calon F, Lavertu N, Lemieux AM, Morissette M, Goulet M, Grondin R, Blanchet PJ, Bédard PJ, Di Paolo T.
    Synapse; 2001 Jun 01; 40(3):225-34. PubMed ID: 11304760
    [Abstract] [Full Text] [Related]

  • 16. Gender differences on MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity in C57BL/6 mice.
    Ookubo M, Yokoyama H, Kato H, Araki T.
    Mol Cell Endocrinol; 2009 Nov 13; 311(1-2):62-8. PubMed ID: 19631714
    [Abstract] [Full Text] [Related]

  • 17. Alteration of dopaminergic markers in gastrointestinal tract of different rodent models of Parkinson's disease.
    Tian YM, Chen X, Luo DZ, Zhang XH, Xue H, Zheng LF, Yang N, Wang XM, Zhu JX.
    Neuroscience; 2008 May 15; 153(3):634-44. PubMed ID: 18420351
    [Abstract] [Full Text] [Related]

  • 18. Telmisartan attenuates MPTP induced dopaminergic degeneration and motor dysfunction through regulation of α-synuclein and neurotrophic factors (BDNF and GDNF) expression in C57BL/6J mice.
    Sathiya S, Ranju V, Kalaivani P, Priya RJ, Sumathy H, Sunil AG, Babu CS.
    Neuropharmacology; 2013 Oct 15; 73():98-110. PubMed ID: 23747572
    [Abstract] [Full Text] [Related]

  • 19. Behavioral and neurochemical effects of wild-type and mutated human alpha-synuclein in transgenic mice.
    Richfield EK, Thiruchelvam MJ, Cory-Slechta DA, Wuertzer C, Gainetdinov RR, Caron MG, Di Monte DA, Federoff HJ.
    Exp Neurol; 2002 May 15; 175(1):35-48. PubMed ID: 12009758
    [Abstract] [Full Text] [Related]

  • 20. Genetic ablation of tumor necrosis factor-alpha (TNF-alpha) and pharmacological inhibition of TNF-synthesis attenuates MPTP toxicity in mouse striatum.
    Ferger B, Leng A, Mura A, Hengerer B, Feldon J.
    J Neurochem; 2004 May 15; 89(4):822-33. PubMed ID: 15140182
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 50.